Report links power lines to cancer

Aug 24, 2007

An Australian study says living next to high-voltage power lines increases the risk of cancer.

Researchers from the University of Tasmania and Britain's Bristol University looked at a database of 850 patients in Tasmania diagnosed with lymphatic and bone marrow cancers between 1972 and 1980, and found that living for a prolonged period near high-voltage power lines may increase the risk of leukemia, lymphoma and related conditions later in life.

Those who lived within 328 yards of a power line up to age 5 were five times more likely to develop cancer, while those who lived that close to a power line at any point during their first 15 years were three times more likely to develop cancer as an adult, the newspaper said.

The study was published in the Internal Medicine Journal.

"The evidence of detrimental long-term health effects is far from conclusive, and international guidelines for limiting exposure to EMF are based on possible short-term effects rather than longer-term disease risks such as cancer," said Ray Lowenthal, a professor at the University of Tasmania.

Copyright 2007 by United Press International

Explore further: New study identifies potential targets for personalized cancer vaccines

add to favorites email to friend print save as pdf

Related Stories

Cosmic jets of young stars formed by magnetic fields

Oct 16, 2014

Astrophysical jets are counted among our Universe's most spectacular phenomena: From the centers of black holes, quasars, or protostars, these rays of matter sometimes protrude several light years into space. ...

Tuning light to kill deep cancer tumors

Oct 15, 2014

An international group of scientists led by Gang Han, PhD, at the University of Massachusetts Medical School, has combined a new type of nanoparticle with an FDA-approved photodynamic therapy to effectively kill deep-set ...

'T-rays' to shed light on nuclear fusion

Oct 09, 2014

In the race to secure clean energy in the future, Lancaster University Engineers are reinventing a piece of technology which so far has only been used in labs to diagnose cancer, detect explosives, and even analyse grand ...

Recommended for you

FOLFOXIRI plus bevacizumab ups outcome in metastatic CRC

13 hours ago

(HealthDay)—For patients with untreated metastatic colorectal cancer, chemotherapy with fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) plus bevacizumab improves outcome versus fluorouracil, ...

User comments : 0